Michael Parini is VP at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have made 53 open-market trades across 1 company since 2017, most recently 2021-02-25.
CIK 0001661567
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 53 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRTX | 33,219 | $16.6M |
Shares reported on the most recent Form 4, priced at the 2021-02-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRTX | SELL | 2021-02-25 | 2021-02-26 | $213.38 | $1.3M | +0.8% | +1.9% | -2.5% |
| VRTX | SELL | 2021-02-18 | 2021-02-19 | $211.81 | $3.3M | +0.8% | +5.9% | +4.8% |
| VRTX | SELL | 2021-02-11 | 2021-02-16 | $210.50 | $1.7M | +1.4% | +1.8% | +3.2% |
| VRTX | SELL | 2021-02-05 | 2021-02-09 | $215.00 | $415K | -0.5% | -0.4% | -1.4% |
| VRTX | SELL · 10b5-1 | 2021-02-03 | 2021-02-05 | $216.56 | $87K | -3.4% | -1.6% | -1.8% |
| VRTX | SELL · 10b5-1 | 2020-11-16 | 2020-11-18 | $223.53 | $20K | +6.4% | +9.4% | -2.8% |
| VRTX | SELL | 2020-11-04 | 2020-11-06 | $217.19 | $643K | -3.6% | +1.2% | -4.8% |
| VRTX | SELL | 2020-08-06 | 2020-08-10 | $271.20 | $663K | +2.0% | -1.1% | -16.2% |
| VRTX | SELL | 2020-08-03 | 2020-08-05 | $278.55 | $852K | +1.7% | -1.0% | -21.6% |
| VRTX | SELL | 2020-07-13 | 2020-07-15 | $291.44 | $685K | -2.7% | -8.5% | -5.5% |
| VRTX | SELL · 10b5-1 | 2020-05-15 | 2020-05-19 | $284.40 | $19K | +0.6% | -2.0% | -3.9% |
| VRTX | SELL | 2020-05-11 | 2020-05-13 | $286.00 | $373K | -4.0% | -3.2% | -5.7% |
| VRTX | SELL | 2020-05-06 | 2020-05-08 | $272.58 | $522K | +4.9% | -2.4% | +0.7% |
| VRTX | SELL | 2020-05-04 | 2020-05-06 | $260.99 | $986K | +4.2% | -2.6% | +1.1% |
| VRTX | SELL | 2020-04-29 | 2020-05-01 | $255.07 | $715K | +7.6% | +11.4% | +8.5% |
| VRTX | SELL | 2020-02-25 | 2020-02-26 | $233.08 | $1.3M | -3.9% | -4.9% | +16.6% |
| VRTX | SELL | 2020-02-18 | 2020-02-19 | $243.73 | $1.4M | -6.1% | -16.7% | +14.1% |
| VRTX | SELL | 2020-02-11 | 2020-02-12 | $246.11 | $8.3M | -4.7% | -8.5% | +14.5% |
| VRTX | SELL | 2020-02-06 | 2020-02-07 | $239.23 | $1.1M | +2.5% | -8.2% | +12.9% |
| VRTX | SELL | 2020-01-31 | 2020-02-04 | $235.37 | $3.2M | +0.9% | -1.8% | +9.6% |
| VRTX | SELL · 10b5-1 | 2020-01-22 | 2020-01-24 | $237.50 | $238 | +6.3% | +4.6% | +18.3% |
| VRTX | SELL | 2020-01-13 | 2020-01-15 | $226.65 | $759K | -1.0% | +4.1% | +12.0% |
| VRTX | SELL | 2020-01-06 | 2020-01-08 | $222.16 | $1.8M | +0.4% | +3.0% | +6.3% |
| VRTX | SELL · 10b5-1 | 2019-11-15 | 2019-11-19 | $205.95 | $17K | +2.8% | +1.4% | +14.5% |
| VRTX | SELL | 2019-11-13 | 2019-11-15 | $205.50 | $1.0M | +4.9% | +4.6% | +14.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.